Fielmann AG
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optik… Read more
Fielmann AG (0MG1) - Net Assets
Latest net assets as of September 2021: €791.05 Million EUR
Based on the latest financial reports, Fielmann AG (0MG1) has net assets worth €791.05 Million EUR as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.72 Billion) and total liabilities (€923.97 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €791.05 Million |
| % of Total Assets | 46.12% |
| Annual Growth Rate | 3.24% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2.65 |
Fielmann AG - Net Assets Trend (2016–2020)
This chart illustrates how Fielmann AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fielmann AG (2016–2020)
The table below shows the annual net assets of Fielmann AG from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | €779.20 Million | +7.83% |
| 2019-12-31 | €722.61 Million | +1.92% |
| 2018-12-31 | €709.01 Million | +2.04% |
| 2017-12-31 | €694.82 Million | +1.28% |
| 2016-12-31 | €686.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fielmann AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 0.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €583.90 Million | 74.94% |
| Common Stock | €84.00 Million | 10.78% |
| Other Components | €111.30 Million | 14.28% |
| Total Equity | €779.20 Million | 100.00% |
Fielmann AG Competitors by Market Cap
The table below lists competitors of Fielmann AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Also Holding AG
SW:ALSN
|
$982.70 Million |
|
Ship Healthcare Holdings Inc
PINK:SHHPF
|
$982.93 Million |
|
CTEEP - Companhia de Transmissão de Energia Elétrica Paulista S.A
SA:TRPL3
|
$983.01 Million |
|
TAIKISHA LTD
F:75L
|
$983.30 Million |
|
Premier Financial Corp
NASDAQ:PFC
|
$982.41 Million |
|
ArcSoft Corp Ltd
SHG:688088
|
$982.32 Million |
|
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263
|
$982.12 Million |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
$981.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fielmann AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 722,613,000 to 779,202,000, a change of 56,589,000 (7.8%).
- Net income of 116,408,000 contributed positively to equity growth.
- Dividend payments of 100,754,000 reduced retained earnings.
- Share repurchases of 336,000 reduced equity.
- Other factors increased equity by 41,271,000.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €116.41 Million | +14.94% |
| Dividends Paid | €100.75 Million | -12.93% |
| Share Repurchases | €336.00K | -0.04% |
| Other Changes | €41.27 Million | +5.3% |
| Total Change | €- | 7.83% |
Book Value vs Market Value Analysis
This analysis compares Fielmann AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Fielmann AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.94%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.15%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 2.14x
- Recent ROE (14.94%) is below the historical average (22.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 24.24% | 12.44% | 1.46x | 1.33x | €97.71 Million |
| 2017 | 24.13% | 12.09% | 1.50x | 1.33x | €98.15 Million |
| 2018 | 23.82% | 11.83% | 1.51x | 1.33x | €97.99 Million |
| 2019 | 23.83% | 11.32% | 1.11x | 1.89x | €99.94 Million |
| 2020 | 14.94% | 8.15% | 0.86x | 2.14x | €38.49 Million |
Industry Comparison
This section compares Fielmann AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fielmann AG (0MG1) | €791.05 Million | 24.24% | 1.17x | $982.64 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |